Follow $RXRX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $RXRX by email
NASDAQ NMS - GLOBAL MARKET · RXRX
-2.64% · -$0.0908 · Vol 10.6M
Market closed · last close 4:00 PM ET · price as of 19:59:37 ET
Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc

Biotechnology
$3.35
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
RXRX
Recursion Pharmaceuticals Inc
Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

39/ 100
Veridion Score
SELL BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is RXRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading RXRX catalysts
About Recursion Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
600
Country
US

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.40
Day high
$3.45
Day low
$3.31
Previous close
$3.44
52W high
$6.79
-50.67% from high
52W low
$2.84
13% of range
Market cap
$1.8B
EPS
$-1.2400
Beta
2.90
Shares out
536.3M
Volume
10.6M
0.65× rel vol
Avg volume
16.1M
VWAP
$3.36
Price history computed in-house
1W
-4.31%
1M
+10.17%
3M
-6.71%
1Y
-28.74%
YTD
-18.11%
SMA 50 $3.31 · above
SMA 200 $3.67 · below
52W position 13%

RXRX overview

Veridion Score
39
Registered · 2026-08-28
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around RXRX.Congress trackerSearch the public STOCK Act disclosure ledger.Thematic map · TechBio & AI Drug DiscoveryMethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading RXRX Form 4 filings
Public disclosures

Congress activity in RXRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for RXRX in the cached public ledger.

Federal contracts

RXRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RXRX in this window.
Lobbying spend

RXRX lobbying filings, year to date.

Registered lobbying filings matched to Recursion Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RXRX in this window.
Loading news for RXRX
Analyst ratings
Sovereign unlock shows live analyst consensus for RXRX.
Options
Sovereign unlock shows live options positioning for RXRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.